PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab

Pfizer Inc. (PFE) along with BioNTech SE (BNTX) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency's (EMA) has rendered a positive opinion recommending marketing authorization for their updated formulation of the mRNA-based COVID-19 vaccine, Comirnaty, which targets the currently circulating KP.2 strain of the Omicron JN.1 lineage.The CHMP recommended marketing approval for Pfizer/BioNTech’s Omicron KP.2-adapted COVID-19 vaccine for individuals aged six ...